SCHEMBL3875478

SCHEMBL3875478

CCCCC1(CC)C(O)C(c2ccccc2)c2cc(SCC(=O)N[C@@H](C(=O)NCCS(=O)(=O)O)c3ccc(O)cc3)ccc2SC1[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MTTP P55157 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931590 0.84 SLC10A2 (0.36) MTTP
SCHEMBL3611683 0.80 SLC10A2 (0.34) MTTP
SCHEMBL5762558 0.79 SLC10A2 (0.53)
Ammonia Solution, Strong SCHEMBL1183723 0.78 SLC10A2 (0.52)
SCHEMBL4790922 0.76 SLC10A2 (0.44)
Ammonia Solution, Strong SCHEMBL3611677 0.76 SLC10A2 (0.49)
SCHEMBL4637650 0.72 NR1H4 (0.41)
Ammonia Solution, Strong SCHEMBL5497725 0.70 SLC10A2 (0.52)
Ammonia Solution, Strong SCHEMBL3875475 0.68
SCHEMBL920147 0.64 SLC10A2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013165-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSOR TION INHIBITOR ACTIVIT. Astra Zeneca AB (SE) 2009-01-14 EP disclosed
WO-2007126358-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSOR TION INHIBITOR ACTIVIT. ASTRAZENECA AB (SE) 2007-11-08 WO disclosed
EP-1699758-A1 DIPHENYLAZETIDINONE DERIVATES PROCESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY AstraZeneca AB (SE) 2006-09-13 EP disclosed
WO-2005061451-A1 DIPHENYLAZETIDINONE DERIVATES PROCESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-07-07 WO disclosed